Mirati Therapeutics | Ativos

Assets Alterar Data
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amgen USD 97.15B 6.62B 2023-12
AstraZeneca USD 96.09B 457M 2023-09
Bayer EUR 117.24B 4.43B 2023-09
Eisai JPY 1.33T 28.9B 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Exelixis USD 2.98B 165.56M 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Incyte USD 6.78B 393.87M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Moderna USD 18.43B 1.02B 2023-12
Pfizer USD 215.02B 5.15B 2023-09
Roche Holding CHF 84.37B 3.78B 2023-06
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Takeda JPY 14.87T 79.15B 2023-09
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12



Mirati Therapeutics Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.